RP Bio Inc. (KOSDAQ:314140)
South Korea · Delayed Price · Currency is KRW 5,200.00
-300.00 (-5.45%)
At close: Jun 19, 2026
RP Bio Market Cap
RP Bio has a market cap or net worth of 45.07 billion as of June 18, 2026. Its market cap has decreased by -8.77% in one year.
Market Cap
45.07B
Enterprise Value
44.59B
Revenue
137.35B
Ranking
n/a
PE Ratio
8.03
Stock Price
5,200.00
Market Cap Chart
Since September 29, 2022, RP Bio's market cap has decreased from 143.18B to 45.07B, a decrease of -68.53%. That is a compound annual growth rate of -26.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 45.07B | -29.73% |
| Dec 30, 2025 | 64.13B | 46.53% |
| Dec 30, 2024 | 43.77B | -41.62% |
| Dec 28, 2023 | 74.96B | -26.88% |
| Dec 29, 2022 | 102.52B | -28.40% |
| Sep 29, 2022 | 143.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Optipharm.CO.,LTD | 68.73B |
| Hwail Pharmaceutical | 68.60B |
| Polaris AI Pharma | 68.41B |
| BL Pharmtech | 64.75B |
| Samik Pharmaceutical Company LTD. | 64.75B |
| Sinil Pharmaceutical | 60.98B |
| Jin Yang Pharmaceutical | 50.93B |
| Korea Arlico Pharm | 40.23B |